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nlineranscatheter closure of prosthetic paravalvular
eaks is increasingly performed at experienced
enters (1–3). The lack of devices dedicated to
aravalvular leak closure has not deterred the
ff-label use of various occluder devices. These
mages illustrate the potential complexity of
ranscatheter paravalvular leak repair with the
eed for additional occluder placement, and the
evelopment of severe leaflet erosion from oc-
luder contact.
rom the *Division of Cardiovascular Medicine, University of California
enter, Mercy General Hospital, Sacramento, California.
Figure 1. Bioprosthetic Mitral Valvular Leaflet Erosion Following
(A) Fluoroscopic view of adjacent Amplatzer Atrial Septal Occluder
paravalvular leak. (B) Transesophageal echocardiographic images d
trudes in the left ventricular (LV) cavity. Note severe regurgitant je
occluder devices and valve. The ASO (*) and AVP (**) are shown, a
aspect of the ASO is visible through the defect in the leaﬂet. (D) E
tricular aspect of excised valve showing large erosion defect in the
tricular disc with multiple wire fractures (small arrows). Also see Oanuscript received July 16, 2009; revised manuscript received August 17, 20A 72-year-old woman who developed acute
itral regurgitation (MR) and cardiogenic shock
n December 2006 underwent emergency mitral
alve replacement with a #25 Hancock II biopros-
hetic valve (Medtronic, Minneapolis, Minnesota),
omplicated by post-operative adult respiratory
istress syndrome, mitral paravalvular leak, hemo-
ytic anemia, and recurrent congestive heart failure.
n April 2007, she had transcatheter mitral para-
alvular leak closure at an outside facility using an
Medical Center, Sacramento, California; and the †Heart and Vascular
scatheter Paravalvular Leak Closure
, *) and Amplatzer Vascular Plug II (AVP, **) occluding the mitral
strating leaﬂet perforation (arrow) from the ASO (*), which pro-
ugh the leaﬂet. (C) Left atrial (LA) intraoperative view of adjacent
l as the eroded posterolateral leaﬂet (arrow). The ventricular
valve and devices, showing relative sizes. (E) Close-up of ven-
erior leaﬂet (arrow). (F) ASO with LA disc (*) and deformed ven-
Videos 1 and 2.Tran
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123-mm Amplatzer Atrial Septal Occluder (AGA Medical
orp., Plymouth, Minnesota), with reduction in the MR as
ell as improvement in hemolytic anemia and congestive
ymptoms. In May 2008, she had progressive paravalvular
eak adjacent to the original occluder with recurrent con-
estive heart failure, left pleural effusion, and hemolysis.
ecause of her high risk for reoperation, she underwent
uccessful percutaneous closure of the remaining lateral
aravalvular leak with placement of a 12-mm Amplatzer
ascular Plug II (AGA Medical Corp.). At that time,
ransesophageal echocardiography showed that the posterior
ioprosthetic leaflet was contacting the previously deployed
mplatzer device during diastole, resulting in moderate
alvular MR.
Although the patient was initially well-compensated, she
eveloped increasing symptomatic valvular MR and 1 year
ater underwent open surgical mitral valve replacement with
#27 Carpentier-Edwards Magna Thermo FX pericardial
alve (Edwards Lifesciences, Irvine, California), as well as
ioprosthetic aortic valve replacement for moderate central
ortic insufficiency. Intraoperative inspection of the biopros-
hetic mitral valve revealed the occluder devices in place, but
ith significant fractures seen in the first occluder, which vas contacting the posterior leaflet, resulting in severe
eaflet erosion and perforation (Fig. 1). The patient’s recov-
ry was uneventful.
eprint requests and correspondence: Dr. Jason H. Rogers,
ivision of Cardiovascular Medicine, University of California
avis Medical Center, 4860 Y Street, Suite 2820, Sacramento,
alifornia 95817. E-mail: jason.rogers@ucdmc.ucdavis.edu.
EFERENCES
. Kim MS, Casserly IP, Garcia JA, Klein AJ, Salcedo EE, Carroll JD.
Percutaneous transcatheter closure of prosthetic mitral paravalvular
leaks: are we there yet? J Am Coll Cardiol Intv 2009;2:81–90.
. Pate GE, Al Zubaidi A, Chandavimol M, Thompson CR, Munt BI,
Webb JG. Percutaneous closure of prosthetic paravalvular leaks: case
series and review. Catheter Cardiovasc Interv 2006;68:528–33.
. Sorajja P, Cabalka AK, Hagler DJ, et al. Successful percutaneous repair
of perivalvular prosthetic regurgitation. Catheter Cardiovasc Interv
2007;70:815–23.
APPENDIX
or Videos 1 and 2 and their accompanying legends, please see the online
ersion of this article.
